Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review
- 1 July 2017
- journal article
- case report
- Published by Elsevier in Transplantation Proceedings
- Vol. 49 (6) , 1409-1418
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirinJournal of Hepatology, 2012
- Liver transplantation for HCV cirrhosis; cautious optimism after 10 years of experienceAnnals of Transplantation, 2012
- Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experienceClinical Transplantation, 2010
- The changing epidemiology of hepatitis C virus infection in EuropeJournal of Hepatology, 2008
- One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infectionLiver Transplantation, 2004
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis CLiver Transplantation, 2003
- Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosisLiver Transplantation, 2003
- Natural history of recurrent hepatitis CLiver Transplantation, 2002
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 2002